Efficacy and safety of pegylated liposomal doxorubicin in combination with bortezomib for multiple myeloma: Effects of adverse prognostic factors on outcome

1. Bladé, J.
2. Sonneveld, P.
3. San Miguel, J.F.
4. Sutherland, H.J.
5. Hajek, R.
6. Nagler, A.
7. Spencer, A.
8. Robak, T.
9. Lantz, K.C.
10. Zhuang, S.H.
11. Harousseau, J.-L.
12. Orlowski, R.Z.